mustbio
Latest round
- Series C
Last raised
- Mar 2026
Total raised
- $44M
Investors
- 10
About mustbio
Based in Suwon-si, South Korea, and founded in 2021, mustbio operates as a biotechnology company that develops new antibody drugs designed to treat cancer. mustbio is a drug and therapeutics developer specializing in cancer treatment. Furthermore, the company is an expert in new drug development, with diverse core technology facilities and successful technology export experiences to multinational pharmaceutical companies that are currently focusing on the development of anti-cancer drug technology based on the developed multi-specific antibody platform technology.
Who invested in mustbio
10 investors across 3 rounds
See all investors in mustbio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about mustbio
Who invested in mustbio?
mustbio has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has mustbio raised?
mustbio has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did mustbio last raise money?
mustbio's most recent round on record is a Series C, in Mar 2026.
What does mustbio do?
Based in Suwon-si, South Korea, and founded in 2021, mustbio operates as a biotechnology company that develops new antibody drugs designed to treat cancer.
Where is mustbio headquartered?
mustbio is headquartered in Suwon, South Korea.
Which VCs invest in companies like mustbio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at mustbio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like mustbio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.